Clinical trial
Safety & Efficacy Study of the Medtronic CoreValve® System-Treatment of…
NCT01675440 · Medtronic Cardiovascular, Industry · Active, not recruiting
Key facts
| NCT number | NCT01675440 |
|---|---|
| Title | Safety & Efficacy Study of the Medtronic CoreValve® System-Treatment of Symptomatic Severe Aortic Stenosis With Significant Comorbidities in Extreme Risk Subjects Who Need Aortic Valve Replacement |
| Official title | Medtronic CoreValve® U.S. Expanded Use Study |
| Lead sponsor | Medtronic Cardiovascular, Industry |
| Status | Active, not recruiting |
| Study type | Observational |
| Conditions | Severe Aortic Stenosis |
| Intervention type | Device |
| Interventions | Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI) |
| Enrollment | 782 |
| Start date | Aug 1, 2012 |
| Primary completion | Dec 1, 2016 |
| Completion | Jan 1, 2026 |
| First posted | Aug 30, 2012 |
| Last update posted | Oct 28, 2025 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: